Pin-Xian Xu

  • ASSOCIATE PROFESSOR Genetics and Genomic Sciences
  • ASSOCIATE PROFESSOR Developmental and Regenerative Biology
Print ProfilePrint Profile

Education

  • B.S., Suzhu University
    Biology

  • M.S., Tottori University
    Biochemistry

  • Ph.D., The Graduate University for Advanced Studies
    Molecular and Developmental Biology

  • National Institute for Basic Biology
    Developmental Biology

  • Harvard Medical School/Brigham & Women's Hospital, Dr. Richard Maas's lab
    Mammalian Development and Molecular Genetics

  • Howard Hughes Medical Institute

  • Harvard Medical School/Brigham & Women's Hospital, Dr. Richard Maas' lab

  • Harvard Medical School/Brigham &Women's Hospital, Genetics Division

  • McLaughlin Research Institute

  • McLaughlin Research Institute

  • Department of Genetics and Genomic Sciences at the Mount Sinai School of Medicine
    secondary appointment at the Department of Molecular, Cell and Developmental Biology

  • Harvard Medical School/Brigham and Women's Hospital

Biography

    Pin-Xian Xu, Ph.D.
    Associate Professor, Genetics And Genomic Sciences
    Associate Professor, Molecular, Cell And Developmental Biology

    Mailing address:
    Department of Genetics and Genomic Sciences
    The Mount Sinai School of Medicine
    East Building, Rm 14-20D
    1425 Madison Avenue
    New York, N.Y.  10029
    Tel:    212-659-6787
    Fax:    212-849-2508

Awards

  • 2007 - 2011
    Member
    NIH

  • 2000 - 2003
    Research Award
    National Science Foundation

  • 1999 - 2000
    Recipient of 50th Anniversary Program for Scholars in Medicine Fellowship
    Harvard Medical School

  • 1997 - 2000
    Individual National Research Service Award
    National Eye Institute/NIH

  • 1995 - 1997
    Research Associate
    Howard Hughes Medical Institute

  • 1993 - 1994
    Daiko Foundation Fellowship and Naito Memorial Foundation Fellowship
    Japan

  • 1987 - 1993
    Graduate Student Scholarship
    Ministry of Education, Science and Culture, Japan

Research

The research in Dr. Xu's laboratory is focused on identifying the genetic pathways that control the critical early steps of mammalian organ formation.  Mainly, the lab is studying the role of the transcription coactivator Eya and its interacting homeodomain protein Six during mammalian organogenesis.  Over the past several years, the team has generated knockout mice for these genes and used the mice to begin to order the actions of these genes into a regulatory pathway.  Dr. Xu's team has taken a multidisciplinary approach to this problem, including the application of experimental embryology, molecular biology, biochemistry, and human and mouse genetics.  Work from the laboratory has shown that these genes are critical regulators for activating specific developmental programs for multiple organ systems.

One major project in the lab is to elucidate the molecular and genetic pathway(s) controlled by Eya and Six genes in early mammalian inner ear morphogenesis. The vertebrate inner ear develops from the otic placode, a one-cell-thick epithelium via multiple inductive processes.  A large number of otic genes have been isolated recently, however, their precise functions are largely unknown and the molecular and genetic pathway(s) regulating the morphogenetic processes of inner ear development are not established.  Recently, it was found that the murine Eya1 gene is expressed during the development of the auditory system and mutations in the human EYA1 gene cause Branchio-Oto-Renal (BOR) syndrome, a congenital birth defect that accounts for as many as 2% of profoundly deaf children. However, despite the identification of the responsible gene for BOR syndrome, the developmental and molecular basis of auditory defects occurring in BOR syndrome and the identity of the steps at which Eya1 functions in early otic development are unclear.  In Eya1-/- mouse embryos, the inner ear development arrests at the otic vesicle stage, indicating that Eya1 is a key gene required for early otic morphogenesis.  Molecularly, it was found that the expression of Six1, which encodes a homeodomain protein, requires Eya1 function in early otic epithelium and their gene products physically interact in vitro.  Moreover, it was recently discovered that Six1 is also a key gene for inner ear development and that mutations in the SIX1 gene also cause BOR syndrome. To dissect the developmental and molecular pathogenesis of auditory system defects occurring in BOR syndrome, Dr. Xu's lab is currently establishing the developmental and molecular basis of inner ear defects associated with Eya1- and Six1-deficiency.  

Another major focus in the lab is to elucidate the molecular mechanisms controlling the formation of a functional metanephric mesenchyme during early kidney development by examining the role of the transcriptional coactivator Eya1, its interacting homeodomain protein Six1 and their cofactors. In addition to the inner ear and kidney, the team recently found that these genes are essential for early cranial sensory neurogenesis. In vertebrates, all peripheral sensory neurons derive either from precursors in placodes or from neural crest cells. Placodes are focal regions of thickened ectoderm in the vertebrate head, which give rise to both neuronal and non-neuronal structures (the lens of the eye and the anterior pituitary). The neurogenic placodes include the olfactory, otic, trigeminal, and epibranchial placodes.  Of these, only the olfactory and otic placodes give rise to neuronal and non-neuronal components, while the trigeminal and epibranchial placodes generate exclusively sensory neurons of the trigeminal and the distal geniculate, petrosal and nodose ganglia. At present, how the placodal ectodermal cells are induced to differentiate into neuronal cells and the molecular mechanisms that direct their development along this pathway are not well established. Dr. Xu'slaboratory is currently investigating the roles of Eya and Six genes in the development of ectoderm-derived neurons.

Publications

Hoskins BE, Cramer II CH, Silvius D, Zou DM, Raymond R, Otto E, Xu PX, Hildebrandt F. The transcription factor SIX5 is mutated in patients With branchio-oto-renal syndrome. Am J Hum Genet 2007;.

Grifone R, Demingnon J, Giordani J, Niro C, Souil E, Bertin F, Laclef C, Xu PX, Maire P. Eya1 and Eya2 proteins are required for hypaxial somatic myogenesis in the mouse embryo.. Dev Biol 2007; 302: 602-616.

Zou D, Silvius D, Rodrigo-Blomqvist S, Enerback S, Xu PX. Eya1 regulates the growth of otic epithelium and interacts with Pax2 during the development of all sensory areas in the inner ear. . Dev Biol 2006; 298: 430-441.

Zou D, Silvius D, Davenport J, Grifone R, Maire P, Xu PX. Patterning of the third pharyngeal pouch into thymus/parathyroid by Six and Eya1. . Dev Biol 2006; 293: 499-512.

Sajithlal G, Silvius D, Zou D, Xu PX. Eya1 acts as a critical regulator for specifying the metanephric mesenchyme.. Dev Biol 2005; 284: 323-336.

Zou D, Silvius D, Fritzsch B, Xu PX. Eya1 and Six1 are essential for early steps of sensory neurogenesis in vertebrate cranial placodes. Development 2004; 131: 5561-5572.

Ruf RG, Xu PX, Silvius D, Otto EA, Beekmann F, Muerb UT, Kumar S, Neuhaus TJ, Kemper MJ, Berkman J, Hyland V, Ruf EM, Schwartz C, Chang EH, Smith RH, Stratakis CA, Weil D, Petit C, Hildebrandt F. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes.. Proc. Natl. Acad. Sci. USA. 2004; 101: 8090-8095.

Zheng W, Huang L, Wei ZB, Silvius D, Tang H, Xu PX. The role of Six1 in mammalian auditory system development.. Development 2003; 130: 3989-4000.

Xu PX, Zheng W, Huang L, Masire P, Laclef C, Silvius D. Six1 is required for the early organogenesis of mammalian kidney. Development 2003; 130: 3085-3094.

Xu PX. Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. Development 2002; 129: 3033-3044.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Xu did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Icahn Medical Institute Floor 14 Room 14-20D
1425 Madison Avenue
New York, NY 10029

Tel: 212-659-6787

Address

Icahn Medical Institute
1425 Madison Avenue
New York, NY 10029